ask="3.25"
ask_size="100"
average_daily_volume="211690"
bid="3.00"
bid_size="200"
book_value="0.56"
change="+0.06"
change_from_200_day_moving_average="0.71"
change_from_50_day_moving_average="0.44"
change_from_52_week_high="-0.72"
change_From_52_week_low="1.09"
change_in_percent="+1.94%"
close="3.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="3.15"
high_52_weeks="3.87"
last_trade_date="2/6/2017"
last_trade_price="3.15"
last_trade_size="100"
last_trade_time="4:00pm"
low="3.01"
low_52_weeks="2.06"
market_capitalization="58.86M"
moving_average_200_day="2.44"
moving_average_50_day="2.71"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="3.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+29.27%"
percent_change_from_50_day_moving_average="+16.31%"
percent_change_from_52_week_high="-18.60%"
percent_change_from_52_week_low="+52.91%"
previous_close="3.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.49"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.29"
stock_exchange="NCM"
symbol="BCLI"
volume="94306"
weeks_range_52="2.06 - 3.87"
